Expression of multidrug resistance markers ABCB 1 ( MDR-1 / Pgp ) and ABCC 1 ( MRP-1 ) in renal cell carcinoma

Walsh Naomi,Larkin Annemarie,K. Susan,C. Lisa,Ballot Jo,Ooi Wei,G. Giuseppe,C. John,Clynes Martin,O. Lorraine

Abstract:Background: Renal cell carcinoma patients respond poorly to conventional chemotherapy, this unresponsiveness may be attributable to multidrug resistance (MDR). The mechanisms of MDR in renal cancer are not fully understood and the specific contribution of ABC transporter proteins which have been implicated in the chemoresistance of various cancers has not been fully defined in this disease. Methods: In this retrospective study the expression of two of these transporter efflux pumps, namely MDR-1 P-gp (ABCB1) and MRP-1 (ABCC1) were studied by immunohistochemistry in archival material from 95 renal cell carcinoma patients. Results: In the first study investigating MDR-1 P-gp and MRP-1 protein expression patterns in renal cell carcinoma patients, high levels of expression of both efflux pumps are observed with 100% of tumours studied showing MDR-1 P-gp and MRP-1 positivity. Conclusion: Although these findings do not prove a causal role, the high frequency of tumours expressing these efflux pumps suggests that they may be important contributors to the chemoresistance of this tumour type. Background Kidney cancer accounts for approximately 2% of all adult cancers. It is the 7th leading cause of cancer in the US with an estimated incidence of approximately 51,000 new cancer cases per year in 2007 [1]. Renal cell carcinoma (RCC) is the most common tumour arising from the cells in the lining of tubules in the kidney [2]. At the time of diagnosis, 30% of patients will have metastatic or unresectable disease, and the 2-year overall survival of this cohort is <10% [3]. The incidence of kidney cancer is rising; it is 2 times more common in men than women. Risk factors include obesity [4], smoking [5] and hypertension [6]. Published: 24 June 2009 BMC Urology 2009, 9:6 doi:10.1186/1471-2490-9-6 Received: 13 March 2009 Accepted: 24 June 2009 This article is available from: http://www.biomedcentral.com/1471-2490/9/6 © 2009 Walsh et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.